Predictors of chronic benzodiazepine use in a health maintenance organization sample

Journal of Clinical Epidemiology

Volumn 49, Issue 9, 1996, Pages 1067-1073

  Simon, Gregory E ^a   VonKorff, Michael ^a   Barlow, William ^a   Pabiniak, Chester ^a   Wagner, Edward ^a  

^a CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Anxiety; Anxiolytics; Benzodiazepines; Epidemiology; Hypnotics; Insomnia

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; LORAZEPAM;

ADULT; AGED; ANXIETY; ARTICLE; DEPRESSION; DRUG CHOICE; DRUG USE; GERIATRICS; HEALTH MAINTENANCE ORGANIZATION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; PAIN; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0030245554     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(96)00139-4     Document Type: Article

References (32)

1. 1. Wysowski D, Baum C. Outpatient use of prescription sedative-hypnotic drugs in the United States, 1970 through 1990. Arch Intern Med 1991; 151: 1779-1883.
2. 2. Mannheimer D, Davidson ST, Balter MB. Popular attitudes and beliefs about tranquilizers. Am J Psychiatry 1973; 130: 1246-1258.
3. 3. Clinthorne J, Cisin IH, Balter MH, Mellinger GD, Uhlenhuth EH. Changes in popular attitudes and beliefs about tranquilizers. Arch Gen Psychiatry 1986; 43: 527-532.
4. 4. Lader M. Dependence on benzodiazepines. J Clin Psychiatry 1983; 44: 121-127.
5. 5. Olfson M, Pincus HA. Use of benzodiazepines in the community. Arch Int Med 1994; 154: 1235-1240.
6. 6. American Psychiatric Association Task Force on Benzodiazepine Toxicity. Benzodiazepine dependence, toxicity, and abuse. American Psychiatric Press, Washington, D.C., 1990.
7. 7. Gillin J, Byerly W. The diagnosis and management of insomnia. N Engl J Med 1990; 322: 239-248.
8. 8. Prinz P, Vitiello M, Raskind M, Thorpy M. Geriatrics: Sleep disorders and aging. N Engl J Med 1990; 323: 520-526.
9. 9. Maletta G, Mattox KM, Dyksen M. Guidelines for prescribing psychoactive drugs in the elderly. Geriatrics 1991; 46: 40-47.
10. 10. NIH Consensus Development Conference. Drugs and insomnia: The use of medications to promote sleep. JAMA 1984; 251: 2410-2414.
11. 11. Oster G, Russell MW, Huse DM, Adams SF, Imbimbo J. Accident-and injury-related health-care utilization among benzodiazepine users and nonusers. J Clin Psychiatry 1987; 48(Suppl.): 17-21.
12. 12. Ray W, Griffin M, Schaffner W, Baugh D, Melton L. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316: 262-369.
13. 13. Sorock G, Shimkin E. Benzodiazepine sedatives and the risk of falling in a community-dwelling elderly cohort. Arch Intern Med 1988; 148: 2441-2444.
14. 14. Tinetti M, Speechley M, Ginter S. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988; 319: 1701-1707.
15. 15. Ray W, Fought R, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 1992; 136: 873-883.
16. 16. Golombok S, Moodley P, Lader M. Cognitive impairment in long-term benzodiazepine users. Psychol Med 1988; 18: 365-374.
17. 17. Nikaido A, Ellinwood E, Heatherly D, Gupta S. Age-related increase in CNS sensitivity to benzodiazepines as assessed by task difficulty. Psychopharmacology 1900; 100: 90-97.
18. 18. Mellinger G, Balter M, Uhlenhuth E. Prevalence and correlates of the long-term regular use of anxiolytic. JAMA 1984; 251: 375-379.
19. 19. Mellinger G, Balter M, Uhlenhuth E. Insomnia and its treatment. Arch Gen Psychiatry 1985; 42: 225-232.
20. 20. Swartz M, Landerman R, George L, Melville M, Blazer D, Smith K. Benzodiazepine anti-anxiety agents: Prevalence and correlates of use in a southern community. Am J Public Health 1991; 81: 592-596.
21. 21. Nolan L, O'Malley K. Patients, prescribing, and benzodiazepines. Eur J Clin Pharmacol 1988; 35: 225-229.
22. 22. North D, McAvoy B, Powell A. Benzodiazepine use in general practice - is it a problem? NZ Med J 1992; 105: 287-289.
23. 23. Isacson D, Carsjo K, Bergman U, Blackburn JL. Long-term use of benzodiazepines in a Swedish community: An eight-year follow-up. J Clin Epidemiol 1992; 45: 429-436.
24. 24. Blenrow G, Romelsjo A, Leifman H, Leifman A, Karlsson G. Sedatives and hypnotics in Stockholm: Social factors and kinds of use. Am J Public Health 1994; 84: 242-246.
25. 25. Mari J, Almeida-Filho N, Coutinho E, Andreoli SB, Miranda CT, Streiner D. The epidemiology of psychotropic drug use in the city of Sao Paulo. Psychol Med 1993; 23: 467-474.
26. 26. Morgan D, Dallossso H, Ebrahim S, Arie T, Fentem PH. Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home. Br Med J Clin Res Ed 1988; 296: 601-602.
27. 27. Saunders K, Stergachis A, VonKorff M. Group Health Cooperative of Puget Sound. In: Pharmacoepidemiology (Strom B, ed.). John Wiley & Sons, New York; 1994.
28. 28. Pregibon D. Resistant fits for some commonly used logistic models with medical applications. Biometrics 1982; 38: 485-498.
29. 29. Lyndon R, Russell J. Benzodiazepine use in a rural general practice population. Aust NZ J Psychiatry 1988; 22: 293-298.
30. 30. Rickels K, Schweizer E, Case WG, Greenblatt DJ. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. Arch Gen Psychiatry 1990; 47: 899-907.
31. 31. Schweizer E, Rickels K, Case WG, Grenblatt DJ. Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper. Arch Gen Psychiatry 1990; 47: 908-915.
32. 32. Pinsker H, Suljaga-Petchel K. Use of benzodiazepines in primary-care geriatric patients. J Am Geriatr Soc 1984; 32: 595-597.